These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 1179225

  • 21. [Chemotherapy-radiotherapy association in the treatment of localized forms of Hodgkin's disease. Prognosis of polychemotherapy after three trials of M.O.P.P].
    Baillet F, Brun B, Mazeron JJ, Rochant H, Pinon G, Reyes F, Vernant JP, Pierquin B, Dreyfus B.
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):457-61. PubMed ID: 917834
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. The cure of Hodgkin's disease with drugs.
    DeVita VT, Hubbard SM, Moxley JH.
    Adv Intern Med; 1983; 28():277-302. PubMed ID: 6188346
    [No Abstract] [Full Text] [Related]

  • 27. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease.
    Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R.
    Cancer Treat Rep; 1984; 68(7-8):947-51. PubMed ID: 6204754
    [Abstract] [Full Text] [Related]

  • 28. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH, Wang SS, Huang Y, Wang B, Huang HQ, Zhang L, Sun XF, Xu RH, Lin TY.
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [Abstract] [Full Text] [Related]

  • 29. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
    Zelechowska JA, Madej G, Piemkowska F.
    Nowotwory; 1976 Aug; 26(3):163-70. PubMed ID: 980801
    [No Abstract] [Full Text] [Related]

  • 30. Involved-field radiotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tirelli U, Bortolus R, van 't Veer MB, Lybeert ML, Keuning JJ, Carde P, Girinsky T, van der Maazen RW, Tomsic R, Vovk M, van Hoof A, Demeestere G, Lugtenburg PJ, Thomas J, Schroyens W, De Boeck K, Baars JW, Kluin-Nelemans JC, Carrie C, Aoudjhane M, Bron D, Eghbali H, Smit WG, Meerwaldt JH, Hagenbeek A, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer Lymphoma Group.
    N Engl J Med; 2003 Jun 12; 348(24):2396-406. PubMed ID: 12802025
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Combined chemotherapy radiotherapy management of stage 3 Hodgkin's disease.
    Gamble JF, Fuller LM, Ibrahim E, Butler JJ, Shullenberger CC.
    Arch Intern Med; 1973 Mar 12; 131(3):435-8. PubMed ID: 4688041
    [No Abstract] [Full Text] [Related]

  • 34. Treatment of advanced Hodgkin's disease with combination chemotherapy.
    Mubashir BA, Shullenberger CC, Gamble JF.
    South Med J; 1973 Jul 12; 66(7):779-84. PubMed ID: 4752227
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Greater curability in advanced Hodgkin's disease?
    Portlock CS.
    Cancer J Sci Am; 1999 Jul 12; 5(5):264-5. PubMed ID: 10526665
    [No Abstract] [Full Text] [Related]

  • 37. Recent advances and controversies in the management of Hodgkin's disease.
    O'Brien PH, Wallace K, Rambo VB.
    Surg Gynecol Obstet; 1975 Mar 12; 140(3):445-51. PubMed ID: 803722
    [Abstract] [Full Text] [Related]

  • 38. Involved-field radiotherapy for patients in partial remission after chemotherapy for advanced Hodgkin's lymphoma.
    Aleman BM, Raemaekers JM, Tomiŝiĉ R, Baaijens MH, Bortolus R, Lybeert ML, van der Maazen RW, Girinsky T, Demeestere G, Lugtenburg P, Lievens Y, de Jong D, Pinna A, Henry-Amar M, European Organization for Research and Treatment of Cancer (EORTC) Lymphoma Group.
    Int J Radiat Oncol Biol Phys; 2007 Jan 01; 67(1):19-30. PubMed ID: 17097834
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.